24 vaccines in human clinical trial stage,150 vaccines in pre-clinical


Deprecated: strlen(): Passing null to parameter #1 ($string) of type string is deprecated in /home/medicircle/public_html/script_newsdetails.php on line 75
▴ inida-frontrunner-corona-vaccine-race-worldwide
WHO Chief Scientist Dr. Soumya Swaminathan says, 24 vaccine candidates in human clinical trial stage, 150 vaccines in pre-clinical stages worldwide

Chief Scientist, World Health Organization Dr. Soumya Swaminathan has said that 24 vaccine candidates are in the human clinical trial stage and 150 vaccines are in the pre-clinical stages worldwide. She said, WHO has a robust pipeline of potential COVID vaccine candidates and the more vaccine candidates will maximize the opportunities.

Dr Swaminathan said, three vaccine candidates are in the Phase-3 trial stage which are Oxford vaccine developed by Astrazeneca, mRNA-1273 by Moderna and the chinease vaccine. She said, vaccine development is lengthy and complex process which takes time, but harmonization at different level will fasten the process. She said, the safety and efficacy of the vaccine is very important in the vaccine development process.

Meanwhile, India has become one of the frontrunners in the global effort to develop a vaccine for the containment of COVID-19. Government agencies have stepped up collaboration with private partners to Fastrack the approval process needed for the development of a potential COVID vaccine.

Human clinical trials of the indigenous COVID vaccines have been started at the various levels in the country to identify the efficacy of these potential vaccines. Bharat Biotech and Zydus Cadila have initiated human clinical trials of their vaccines after getting approval from the government.

Government has assured to provide all the necessary support for the development of vaccine saying that all the regulatory process will be ensured. ICMR and Bharat Biotech have joined hands for the development of potential COVID-19 vaccine called 'Covaxin' whereas the Department of Biotechnology has partially funded the development of Zydus's vaccine ZyCov-D. India is considered a pharmacy of the world and 60 percent of the vaccine at the world level is supplied by India.

A top Indian pharma company Serum Institute of India has bagged a contract with British drugmaker AstraZeneca to supply one billion doses of Oxford University's potential COVID-19 vaccine. This vaccine is currently at the third level of the human clinical trial stage.

Tags : #CoronaVaccine #WHO #BharatBiotech #ZydusCadila #Zycov-D #Covaxin #ICMR #AstraZeneca #SerumInstitute

About the Author


Team Medicircle

Related Stories

Loading Please wait...

-Advertisements-




Trending Now

Digital Identity Fraud in Healthcare: What India Must KnowNovember 18, 2026
Wearables in Clinical Care: When Should Doctors Trust the Data?November 18, 2026
Cybersecurity for Medical Startups: What Founders MissNovember 18, 2026
Remote Patient Monitoring: The Next Phase of Virtual CareNovember 18, 2026
Digital Health Wallets: Future of Medical Records in IndiaNovember 17, 2026
How Hospitals Can Prepare for a Transparent Healthcare MarketNovember 17, 2026
Childhood Nutrition: Understanding Micronutrient Gaps Beyond CaloriesNovember 16, 2026
Anaemia in Adolescent Girls: Connecting Prevention, Testing and Nutrition SupportNovember 16, 2026
Health Information Exchanges in India: Are Medical Records Finally Going Portable?November 16, 2026
Hospital Accreditation in 2026: What Is Changing Beyond the Checklist?November 16, 2026
Digital Insurance Platforms and India's Health Coverage FutureNovember 14, 2026
ABDM 2.0: India's Digital Health Ecosystem FutureNovember 14, 2026
Vaccine Cold-Chain Management: Protecting Immunisation Quality From Storage to DeliveryNovember 14, 2026
Foodborne Illness Surveillance: How Public Health Systems Track RisksNovember 14, 2026
Interoperability in Indian Healthcare: Why Patient Data Still StrugglesNovember 13, 2026
Tuberculosis Contact Screening: How Preventive Care Works Around ExposureNovember 13, 2026
COPD Care in India: Linking Diagnosis, Inhaler Education and Follow-UpNovember 13, 2026
Management of ANCA Glomerulonephritis: Induction & Maintenance ProtocolsNovember 12, 2026
Smart Hospital Command Centres Transforming IndiaNovember 12, 2026
Gamma Knife Surgery in India: What You Need to KnowNovember 12, 2026